>AT2G44980.1 | transcription regulatory protein SNF2 putative
MSKESSPPKVPSTTMEYERRLEAAAEIILEKEAKFSNTPPDCSEFGVTATLKPHQVEGVS
WLIQKYLLGVNVVLELDQMGLGKTLQAISFLSYLKFRQGLPGPFLVLCPLSVTDGWVSEI
NRFTPNLEVLRYVGDKYCRLDMRKSMYDHGHFLPFDVLLTTYDIALVDQDFLSQIPWQYA
IIDEAQRLKNPNSVLYNVLLEQFLIPRRLLITGTPIQNNLTELWALMHFCMPLVFGTLDQ
FLSAFKETGDGLDVSNDKETYKSLKFILGAFMLRRTKSLLIESGNLVLPPLTELTVMVPL
VSLQKKIYTSILRKELPGLLELSSGGSNHTSLQNIVIQLRKACSHPYLFPGIEPEPFEEG
EHLVQASGKLLVLDQLLKRLHDSGHRVLLFSQMTSTLDILQDFMELRRYSYERLDGSVRA
EERFAAIKNFSVDGSNAFVFMISTRAGGVGLNLVAADTVIFYEQDWNPQVDKQALQRAHR
IGQISHVLSINLVTEHSVEEVILRRAERKLQLSHNVVGDNMEEKEEDGGDLRSLVFGLQR
FDPEEIHNEESDNLKMVEISSLAEKVVAIRQNVEPDKEERRFEINSSDTLLGNTSSASLD
SELDEASYLSWVEKLKEAARSSKDEKIIELGNRKNLSEERNLRIEAARKKAEEKKLATWG
AHGYQSLSVEEPILPDDVDSSSDAGSVNFVFGDCTNPSTVSHEPAIIFSCVDDSGNWGRG
GMFDALSKLSNTVPTAYHRASEFKDLHLGDLHLIKIDDNDDQQNTQASKPLWVAVAVTQS
YNSRRKVPRSSISIPDLESCLAKASFSASQKSASLHMPRIGYQDGSDRSQWYTVERLLRK
YSSIFTVKIFV*
>AT2G44980.1 | transcription regulatory protein SNF2 putative
MSKESSPPKVPSTTMEYERRLEAAAEIILEKEAKFSNTPPDCSEFGVTATLKPHQVEGVS
WLIQKYLLGVNVVLELDQMGLGKTLQAISFLSYLKFRQGLPGPFLVLCPLSVTDGWVSEI
NRFTPNLEVLRYVGDKYCRLDMRKSMYDHGHFLPFDVLLTTYDIALVDQDFLSQIPWQYA
IIDEAQRLKNPNSVLYNVLLEQFLIPRRLLITGTPIQNNLTELWALMHFCMPLVFGTLDQ
FLSAFKETGDGLDVSNDKETYKSLKFILGAFMLRRTKSLLIESGNLVLPPLTELTVMVPL
VSLQKKIYTSILRKELPGLLELSSGGSNHTSLQNIVIQLRKACSHPYLFPGIEPEPFEEG
EHLVQASGKLLVLDQLLKRLHDSGHRVLLFSQMTSTLDILQDFMELRRYSYERLDGSVRA
EERFAAIKNFSVDGSNAFVFMISTRAGGVGLNLVAADTVIFYEQDWNPQVDKQALQRAHR
IGQISHVLSINLVTEHSVEEVILRRAERKLQLSHNVVGDNMEEKEEDGGDLRSLVFGLQR
FDPEEIHNEESDNLKMVEISSLAEKVVAIRQNVEPDKEERRFEINSSDTLLGNTSSASLD
SELDEASYLSWVEKLKEAARSSKDEKIIELGNRKNLSEERNLRIEAARKKAEEKKLATWG
AHGYQSLSVEEPILPDDVDSSSDAGSVNFVFGDCTNPSTVSHEPAIIFSCVDDSGNWGRG
GMFDALSKLSNTVPTAYHRASEFKDLHLGDLHLIKIDDNDDQQNTQASKPLWVAVAVTQS
YNSRRKVPRSSISIPDLESCLAKASFSASQKSASLHMPRIGYQDGSDRSQWYTVERLLRK
YSSIFTVKIFV*
>AT2G44980.2 | transcription regulatory protein SNF2 putative
MSKESSPPKVPSTTMEYERRLEAAAEIILEKEAKFSNTPPDCSEFGVTATLKPHQVEGVS
WLIQKYLLGVNVVLELDQMGLGKTLQAISFLSYLKFRQGLPGPFLVLCPLSVTDGWVSEI
NRFTPNLEVLRYVGDKYCRLDMRKSMYDHVKKSSKGHFLPFDVLLTTYDIALVDQDFLSQ
IPWQYAIIDEAQRLKNPNSVLYNVLLEQFLIPRRLLITGTPIQNNLTELWALMHFCMPLV
FGTLDQFLSAFKETGDGLSGLDVSNDKETYKSLKFILGAFMLRRTKSLLIESGNLVLPPL
TELTVMVPLVSLQKKIYTSILRKELPGLLELSSGGSNHTSLQNIVIQLRKACSHPYLFPG
IEPEPFEEGEHLVQASGKLLVLDQLLKRLHDSGHRVLLFSQMTSTLDILQDFMELRRYSY
ERLDGSVRAEERFAAIKNFSAKTERGLDSEVDGSNAFVFMISTRAGGVGLNLVAADTVIF
YEQDWNPQVDKQALQRAHRIGQISHVLSINLVTEHSVEEVILRRAERKLQLSHNVVGDNM
EEKEEDGGDLRSLVFGLQRFDPEEIHNEESDNLKMVEISSLAEKVVAIRQNVEPDKEERR
FEINSSDTLLGNTSSASLDSELDEASYLSWVEKLKEAARSSKDEKIIELGNRKNLSEERN
LRIEAARKKAEEKKLATWGAHGYQSLSVEEPILPDDVDSSSDAGSVNFVFGDCTNPSTVS
HEPAIIFSCVDDSGNWGRGGMFDALSKLSNTVPTAYHRASEFKDLHLGDLHLIKIDDNDD
QQNTQASKPLWVAVAVTQSYNSRRKVPRSSISIPDLESCLAKASFSASQKSASLHMPRIG
YQDGSDRSQWYTVERLLRKYSSIFTVKIFVYYYRRSP*
>AT2G44980.2 | transcription regulatory protein SNF2 putative
MSKESSPPKVPSTTMEYERRLEAAAEIILEKEAKFSNTPPDCSEFGVTATLKPHQVEGVS
WLIQKYLLGVNVVLELDQMGLGKTLQAISFLSYLKFRQGLPGPFLVLCPLSVTDGWVSEI
NRFTPNLEVLRYVGDKYCRLDMRKSMYDHVKKSSKGHFLPFDVLLTTYDIALVDQDFLSQ
IPWQYAIIDEAQRLKNPNSVLYNVLLEQFLIPRRLLITGTPIQNNLTELWALMHFCMPLV
FGTLDQFLSAFKETGDGLSGLDVSNDKETYKSLKFILGAFMLRRTKSLLIESGNLVLPPL
TELTVMVPLVSLQKKIYTSILRKELPGLLELSSGGSNHTSLQNIVIQLRKACSHPYLFPG
IEPEPFEEGEHLVQASGKLLVLDQLLKRLHDSGHRVLLFSQMTSTLDILQDFMELRRYSY
ERLDGSVRAEERFAAIKNFSAKTERGLDSEVDGSNAFVFMISTRAGGVGLNLVAADTVIF
YEQDWNPQVDKQALQRAHRIGQISHVLSINLVTEHSVEEVILRRAERKLQLSHNVVGDNM
EEKEEDGGDLRSLVFGLQRFDPEEIHNEESDNLKMVEISSLAEKVVAIRQNVEPDKEERR
FEINSSDTLLGNTSSASLDSELDEASYLSWVEKLKEAARSSKDEKIIELGNRKNLSEERN
LRIEAARKKAEEKKLATWGAHGYQSLSVEEPILPDDVDSSSDAGSVNFVFGDCTNPSTVS
HEPAIIFSCVDDSGNWGRGGMFDALSKLSNTVPTAYHRASEFKDLHLGDLHLIKIDDNDD
QQNTQASKPLWVAVAVTQSYNSRRKVPRSSISIPDLESCLAKASFSASQKSASLHMPRIG
YQDGSDRSQWYTVERLLRKYSSIFTVKIFVYYYRRSP*
>AT3G54980.1 | pentatricopeptide (PPR) repeat-containing protein
MRSLLVFRKIPSRIRLRNLRNNKPFCSQSQFPKESENPSQEQRLLVYGSTSEENPVTSKV
SLLSAKPEQKDDASVIDVLLNRRNNPEAALRFYNWARPWRGSFEDGDVFWVLIHILVSSP
ETYGRASDLLIRYVSTSNPTPMASVLVSKLVDSAKSFGFEVNSRAFNYLLNAYSKDRQTD
HAVDIVNQMLELDVIPFFPYVNRTLSALVQRNSLTEAKELYSRMVAIGVDGDNVTTQLLM
RASLREEKPAEALEVLSRAIERGAEPDSLLYSLAVQACCKTLDLAMANSLLREMKEKKLC
VPSQETYTSVILASVKQGNMDDAIRLKDEMLSDGISMNVVAATSLITGHCKNNDLVSALV
LFDKMEKEGPSPNSVTFSVLIEWFRKNGEMEKALEFYKKMEVLGLTPSVFHVHTIIQGWL
KGQKHEEALKLFDESFETGLANVFVCNTILSWLCKQGKTDEATELLSKMESRGIGPNVVS
YNNVMLGHCRQKNMDLARIVFSNILEKGLKPNNYTYSILIDGCFRNHDEQNALEVVNHMT
SSNIEVNGVVYQTIINGLCKVGQTSKARELLANMIEEKRLCVSCMSYNSIIDGFFKEGEM
DSAVAAYEEMCGNGISPNVITYTSLMNGLCKNNRMDQALEMRDEMKNKGVKLDIPAYGAL
IDGFCKRSNMESASALFSELLEEGLNPSQPIYNSLISGFRNLGNMVAALDLYKKMLKDGL
RCDLGTYTTLIDGLLKDGNLILASELYTEMQAVGLVPDEIIYTVIVNGLSKKGQFVKVVK
MFEEMKKNNVTPNVLIYNAVIAGHYREGNLDEAFRLHDEMLDKGILPDGATFDILVSGQV
GNLQPVRAASL*
>AT2G32390.1 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.1 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MILSLEERPNLRLWRPLKTLMLTRVSSGAPSLILSSRTLIAVDLLAPWELMENKVVAAIG
PQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQNDYFQMNAITDFVSYF
RWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGADNSSISDLLASVNLMES
RIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSMEPLDPRALDLLQGVVA
FRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSVWLVARALDVFFSQGNT
VTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLTGQIEFNSEKNRINPAY
DILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRLNEIIWPGEVIKPPRGW
VFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAIQLLPYPVPRTYILYGD
GKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIESGLVVVAPVKGAKSSP
WSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQIITVFWFSFSTMFFSH
RENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRIEGMDTLIASNEPIGVQ
DGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAAIVDELPYIKALLSNSN
CKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEKIRKKWLTYDHECTMQI
SDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRPEESDEVQARSEEAGSS
RGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAENSQSKDHETPQ*
>AT2G32390.2 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE
NSQSKDHETPQ*
>AT2G32390.2 | ATGLR35 (GLUTAMATE RECEPTOR 35) intracellular ligand-gated ion channel
MGALQLMENKVVAAIGPQSSGIGHIISHVANELHVPFLSFAATDPTLSSLQYPYFLRTTQ
NDYFQMNAITDFVSYFRWREVVAIFVDDEYGRNGISVLGDALAKKRAKISYKAAFPPGAD
NSSISDLLASVNLMESRIFVVHVNPDSGLNIFSVAKSLGMMGSGYVWITTDWLLTALDSM
EPLDPRALDLLQGVVAFRHYTPESDNKRQFKGRWKNLRFKESLKSDDGFNSYALYAYDSV
WLVARALDVFFSQGNTVTFSNDPSLRNTNDSGIKLSKLHIFNEGERFLQVILEMNYTGLT
GQIEFNSEKNRINPAYDILNIKSTGPLRVGYWSNHTGFSVAPPETLYSKPSNTSAKDQRL
NEIIWPGEVIKPPRGWVFPENGKPLKIGVPNRVSYKNYASKDKNPLGVKGFCIDIFEAAI
QLLPYPVPRTYILYGDGKKNPSYDNLISEVAANIFDVAVGDVTIITNRTKFVDFTQPFIE
SGLVVVAPVKGAKSSPWSFLKPFTIEMWAVTGALFLFVGAVIWILEHRFNEEFRGPPRRQ
IITVFWFSFSTMFFSHRENTVSTLGRFVLLVWLFVVLIINSSYTASLTSILTVQQLTSRI
EGMDTLIASNEPIGVQDGTFAWKFLVNELNIAPSRIIPLKDEEEYLSALQRGPRGGGVAA
IVDELPYIKALLSNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLAEEGKLEK
IRKKWLTYDHECTMQISDTENYQISVQSFWGLFLICGVVWFIALTLFCWKVFWQYQRLRP
EESDEVQARSEEAGSSRGKSLRAVSFKDLIKVVDKREAEIKEMLKEKSSKKLKDGQSSAE
NSQSKDHETPQ*
>AT1G71790.1 | F-actin capping protein beta subunit family protein
MEAALGLLRRMPPKQSETALSALLSLIPQHSSDLLSQVDLPLQVLRDIESGKDFILCEYN
RDADSYRSPWSNKYLPPLEDALYPSSELRKLEVEANDIFAIYRDQYYEGGISSVYMWEDD
NEGFVACFLIKKDGSKSGHGRRGCLEEGAWDAIHVIQVGSEEEEMAQYCLTSTIMLSLTT
DDESSGKFGLSGSIRRQMKMELAVADGHLCNMGRMIEELEGKLRNSLDQVYFGKTREMVC
TLRPPAEIVQMRLPDT*
>AT2G04300.1 | leucine-rich repeat protein kinase putative
MKTHPQAILLCVLFFITFGLLHVVEAGNQEGFISLDCGLSPNEPPYVDAATDLTYTTDND
FVQSGKTGTIDKELESTYNKPILQLRYFPEGVRNCYTLNVTLGTNYLIRASFVYGNYDGL
NKELEFDLYLGPNLWANVNTAVYLMNGVTTEEIIHSTKSKVLQVCLIKTGESIPIINSLE
LRPLINDTYNTQSGSLKYLFRNYFSTSRRIIRYPNDVNDRHWYPFFDEDAWTELTTNLNV
NSSNGYDPPKFVMASASTPISKNAPFNFTWSLIPSTAKFYSYMHFADIQTLQANETREFD
MMLNGNLALERALEVFTVIDFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKRFMW
DGLNCNNSYISTPPTITFLNLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPEFLAG
LKSLLVINLSGNNLSGSVPQTLLQKKGLKLNLEGNIYLNCPDGSCVSKDGNGGAKKKNVV
VLVVVSIALVVVLGSALALFLVFRKRKTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMT
NNFEKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHKNLVGL
VGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKP
PMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWL
NEKSDVYSFGIVLLEIITNQHVINQSREKPHIAEWVGVMLTKGDIKSIIDPKFSGDYDAG
SVWRAVELAMSCVNPSSTGRPTMSQVVIELNECLASENSRRGMSQNMESKGSIQYTEVST
NFGTEYTPEAR*